In the battle against drug-resistant infections, a groundbreaking development has emerged with the introduction of a new class of antibiotics from Kinvard Bio.This innovative startup, stemming from Harvard University, aims to combat the escalating threat of antibiotic resistance that poses a significant health crisis worldwide.